- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
31 Eczema Trials near Indianapolis, IN
Power is an online platform that helps thousands of Eczema patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerLebrikizumab for Eczema
Trial Details
Key Eligibility Criteria
206 Participants Needed
Abrocitinib for Eczema
Trial Details
Key Eligibility Criteria
150 Participants Needed
Amlitelimab for Eczema
Trial Details
Key Eligibility Criteria
961 Participants Needed
Camoteskimab for Eczema
Trial Details
Key Eligibility Criteria
62 Participants Needed
Rezpegaldesleukin for Atopic Dermatitis
Trial Details
Key Eligibility Criteria
396 Participants Needed
Amlitelimab + Topical Corticosteroids for Atopic Dermatitis (AQUA)
Trial Details
Key Eligibility Criteria
249 Participants Needed
Abrocitinib for Eczema
Trial Details
Key Eligibility Criteria
500 Participants Needed
Upadacitinib vs Dupilumab for Eczema
Trial Details
Key Eligibility Criteria
675 Participants Needed
RO7790121 for Eczema
Trial Details
Key Eligibility Criteria
160 Participants Needed
Abrocitinib for Atopic Dermatitis/Eczema
Trial Details
Key Eligibility Criteria
3165 Participants Needed
Upadacitinib for Eczema
Trial Details
Key Eligibility Criteria
912 Participants Needed
Upadacitinib + Topical Corticosteroids for Eczema
Trial Details
Key Eligibility Criteria
1500 Participants Needed
PF-07275315 + PF-07264660 for Eczema
Trial Details
Key Eligibility Criteria
340 Participants Needed
Nemolizumab for Eczema
Trial Details
Key Eligibility Criteria
1700 Participants Needed
Nemolizumab for Eczema
Trial Details
Key Eligibility Criteria
105 Participants Needed
Upadacitinib for Eczema
Trial Details
Key Eligibility Criteria
300 Participants Needed
Rocatinlimab for Atopic Dermatitis/Eczema
Trial Details
Key Eligibility Criteria
2200 Participants Needed
Rocatinlimab for Atopic Dermatitis
Trial Details
Key Eligibility Criteria
532 Participants Needed
Lebrikizumab for Eczema
Trial Details
Key Eligibility Criteria
1188 Participants Needed
LEO 138559 for Eczema
Trial Details
Key Eligibility Criteria
262 Participants Needed
Why Other Patients Applied
"I have dealt with voice and vocal fold issues related to paralysis for over 12 years. This problem has negatively impacted virtually every facet of my life. I am an otherwise healthy 48 year old married father of 3 living. My youngest daughter is 12 and has never heard my real voice. I am now having breathing issues related to the paralysis as well as trouble swallowing some liquids. In my research I have seen some recent trials focused on helping people like me."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
Lebrikizumab for Eczema
Trial Details
Key Eligibility Criteria
120 Participants Needed
Ruxolitinib Cream for Atopic Dermatitis/Eczema
Trial Details
Key Eligibility Criteria
100 Participants Needed
Lebrikizumab for Eczema
Trial Details
Key Eligibility Criteria
80 Participants Needed
Lunsekimig for Eczema
Trial Details
Key Eligibility Criteria
144 Participants Needed
Ruxolitinib Cream for Hand Eczema
Trial Details
Key Eligibility Criteria
186 Participants Needed
Tralokinumab for Atopic Hand Eczema
Trial Details
Key Eligibility Criteria
402 Participants Needed
ATI-2138 for Eczema
Trial Details
Key Eligibility Criteria
14 Participants Needed
CGB-500 Ointment for Eczema
Trial Details
Key Eligibility Criteria
180 Participants Needed
ATTO-1310 for Atopic Dermatitis
Trial Details
Key Eligibility Criteria
104 Participants Needed
Dupilumab for Eczema
Trial Details
Key Eligibility Criteria
880 Participants Needed
Know someone looking for new options?
Spread the word